Conclusion-In stable angina, myocardial ischaemia is usually painful and demand driven, whereas in the early period after infarction silent, supply driven ischaemia predominates. The failure of myocardial ischaemia to provoke symptoms in some patients with stable angina may be related to autonomic dysfunction affecting the sensory supply to the heart. In the early period after infarction despite clear evidence of autonomic dysfunction, other mechanisms must also be important as there was no tendency for the reduction in heart rate variability to be exaggerated in the subgroup with silent exertional ischaemia. (Br HeartJ 1993;70:438-442) In the Framingham study, more than 10% of all myocardial infarctions were silent' and more recent work has shown that ischaemia early after the acute attack is also commonly silent.2A Despite this, investigation of the pathophysiology of silent ischaemia has been largely confined to patients with stable angina and much less is known about its mechanism in acute myocardial infarction.
40% of group B (p < 0.005). During Holter monitoring, ST depression was associated with an attenuated increase in rate in group A and almost no increase in rate in group B (18X2% v 3X7%; p < 0-005), suggesting that reductions in myocardial oxygen delivery were contributing to the ischaemic episodes, particularly in group B. Ischaemic episodes were more commonly silent during Holter monitoring, particularly patients in group B, only two of whom experienced angina in association with ST depression. Spectral and non-spectral measures of heart rate variability were significantly reduced in group B compared with group A. Patients with silent exertional ischaemia in group A had significantly less heart rate variability than patients who experienced angina but this difference was not seen in group B.
Conclusion-In stable angina, myocardial ischaemia is usually painful and demand driven, whereas in the early period after infarction silent, supply driven ischaemia predominates. The failure of myocardial ischaemia to provoke symptoms in some patients with stable angina may be related to autonomic dysfunction affecting the sensory supply to the heart. In the early period after infarction despite clear evidence of autonomic dysfunction, other mechanisms must also be important as there was no tendency for the reduction in heart rate variability to be exaggerated in the subgroup with silent exertional ischaemia.
(Br HeartJ 1993;70:438-442)
In the Framingham study, more than 10% of all myocardial infarctions were silent' and more recent work has shown that ischaemia early after the acute attack is also commonly silent.2A Despite this, investigation of the pathophysiology of silent ischaemia has been largely confined to patients with stable angina and much less is known about its mechanism in acute myocardial infarction.
In stable angina, abnormalities of pain perception may account for the increased prevalence of silent ischaemia that occurs in certain clinical subgroups, particularly diabetic5 and elderly6 7 patients. The propensity of these patients to silent ischaemia is commonly attributed to autonomic dysfunction affecting the sensory innervation of the heart.8 Autonomic dysfunction is also common early after myocardial infarction, possibly because of destruction of neuroreceptors and neural pathways within and around the infarcted territory.9 Whether this creates zones of myocardium that are prone to developing silent ischaemia remains speculative.'0 (5) (range 48-174) hours after the onset of infarction when the patients were mobile. Before the recording, 12 lead electrocardiograms were recorded in the sitting, standing, supine, and left and right lateral positions, to ensure that ST segments did not change with posture. Lead CMV5 and modified lead 2 were used. Recordings were made with a Marquette Series 8000, and analysed with a Marquette Holter Acquisition Module software version 5-8. The time and duration of episodes of ST depression were documented. An episode was defined as ischaemia lasting for > 1 minute; the ST segment had to return to baseline for two minutes before a second episode could be counted. The occurrence of angina was indicated by pressing a button on the recorder and keeping a diary.
HEART RATE VARIABILITY
The first 24 hours of Holter recordings were analysed for heart rate variability with Marquette heart rate variability software. The spectral and non-spectral indices measured were: amplitude of high frequency (0-1 5-0 40 Hz) and low frequency (0-04-0 15 Hz) peaks, SD of five minute mean RR intervals (SDANN), root mean square of difference of successive RR intervals (rMSSD), and proportion of adjacent RR intervals more than 50 ms different (pNN50).
STATISTICAL ANALYSIS
All averaged results are expressed as means (SEM). Groups A and B, and exercise and Holter data were compared by the unpaired t test for normally distributed variables and by the Mann-Whitney U test for other variables (duration of ischaemia and pNN50). Number of diabetic patients, sex distribution and the presence of angina on the treadmill test in groups A and B were compared with the x2 test. Two sided p < 0 05 was considered significant.
The study was approved by the Newham Health District Ethics Committee, and written informed consent was given by all patients.
Results
The two groups comprised 35 patients with stable angina (group A) and 40 patients with recent myocardial infarction (group B). There were no significant differences between the groups in age (62 (2), v 60 (1) years), sex Increase in heart rate (%) 18-2(3-0) 3-7(1-6)** 1-7(2-1)** *p < 0 05 and **p < 0-005 v group A.
Other explanations as for table 1. Relation between ST depression and changes in heart rate Immediately before episodes of ST depression average heart rates were similar in groups A and B but ST depression was associated with a significantly greater increase in heart rate in group A than in group B. This difference persisted when group B data were confined to those 24 patients not taking ,Bblockers (group B(i)) (table 2).
HEART RATE VARIABILITY Spectral and non-spectral measures of heart rate variability were significantly reduced in group B compared with group A, irrespective of treatment with blockers (table 3) . Analysis according to the symptomatic response to treadmill exercise (table 4) showed that in group A patients who experienced no chest pain had significantly lower spectral and non-spectral measures of heart rate variability than patients who experienced agina. In group B, on the other hand, patients with silent ischaemia on the treadmill had no reduction in heart rate variability compared with the symptomatic group, irrespective of (2) 17 (1)** 13 (2) 15 (2) 12 (2) 15 (3) High frequency peak (ms) 11 (1) 8 (1)* 7 ( 1) 8 (1) 6 (1) 8 (1) SDANN (ms) 130 (7) 112 (10) 70 (5) 75 (6) 64 (6) 76 (9) rMSSD (ms)
28 (3) 19 (2)* 20 (2) 23 (2) 19 (2) 22 (3) pNN50 (%)
7-1 (1-8) 2-6 (0.9)* 2-9 (0-8)
See footnote to tables 1 and 3 for abbreviations. The resting heart rate for both tests was similar and showed no significant differences between groups A and B (table 5) . During the exercise test, ischaemic ST depression was associated with a sharp increase in heart rate in both groups but during Holter monitoring it was associated with a much smaller increase, particularly in group B. Consequently, in both groups the heart rate at peak ST depression was significantly higher during the exercise test than during Holter monitoring. This difference persisted when analysis of the responses in group B was confined to group B(i).
Discussion
This study of myocardial ischaemia has provided a direct comparison between patients with stable angina and patients with recent myocardial infarction. The data point to important differences between the mechanisms of ischaemia and its symptoms in the two groups. Nevertheless, it is clear from the treadmill data that in both groups demand driven myocardial ischaemia can be provoked. Thus exercise produced similar increments in heart rate and blood pressure until the inability of oxygen supply in the diseased coronary arteries to keep pace with increasing demand led to ischaemic changes on the electrocardiogram. The ST changes occurred at almost identical average workloads and ratepressure products, confirming that during the treadmill test increased oxygen demand was the principle mechanism of ischaemia. Periodic increments in oxygen demand may also have contributed to ischaemia during Holter monitoring, particularly in the patients with stable angina in whom ST change was associated with a significant increase in heart rate. This is unlikely, however, to be the only mechanism because the increase in heart rate was considerably lower than that which provoked ST depression during the treadmill stress test, suggesting that reductions in myocardial oxygen delivery contributed greatly to ischaemia during H1o1ter monitoring. Our data do not permit firm conclusions about the cause of these inappropriate reductions in oxygen delivery (presumably they relate to alterations in coronary vasomotor tone) but the finding that patients with stable angina are susceptible to both demand driven and supply driven ischaemia during Holter monitoring is consistent with reports from other investigators."' By contrast with the patients with stable angina, the patients studied early after myocardial infarction showed ST depression with almost no increase in heart rate during Holter monitoring. Clearly, these ischaemic episodes cannot be readily explained by alterations in oxygen demand, unlike those documented during the treadmill stress test. Periodic reductions in oxygen delivery, therefore, are likely to be the dominant mechanism of ischaemia in this group, a conclusion supported by the findings of Currie and Saltissi."2 These investigators showed that increments in heart rate during ischaemia on Holter monitoring in the early period after infarction (six days) were less pronounced than later recordings (38 days) when demand driven ischaemia is likely to become more prominent. Again, our data do not permit firm conclusions about the mechanism of supply driven ischaemia early after infarction, but it is possible to speculate that it relates to continuing instability of the coronary plaque in the infarct related artery after successful thrombolytic treatment, with intermittent platelet aggregation and thrombus formation leading to variable luminal obstruction and reductions in oxygen delivery. This is analogous to the mechanism that explains the increased risk of reinfarction early after thrombolytic treatment.
Ischaemic episodes were more commonly silent in the patients with recent infarction than in the patients with stable angina. It has been suggested that the propensity of patients with recent infarction to silent ischaemia reflects damage to the sensory innervation of the heart.'3 Certainly the heart rate variability data in our study points to significant autonomic dysfunction in the group with recent infarction and, because myocardial sensory afferents are thought to reside in the autonomic supply, this may have contributed to the heightened susceptibility to silent ischaemia during the treadmill test and Holter monitoring. Nevertheless, this is unlikely to provide the full explanation because in the subgroup analysis ( The major differences between the groups persisted, confirming that they cannot be attributed to the effects of,B blockers.
In conclusion, myocardial ischaemia in both stable angina and recent infarction may be symptomatic or silent and may be demand driven or supply driven. This comparative study has confirmed that in stable angina painful, demand driven ischaemia is relatively more common whereas in the early period after infarction silent, supply driven ischaemia predominates. The data indicate that the failure of myocardial ischaemia to provoke symptoms in some patients with stable angina may be related to autonomic dysfunction affecting the sensory supply to the heart. In the early period after infarction, despite clear evidence of autonomic dysfunction, other mechanisms must also be important as there was no tendency for the reduction in heart rate variability to be exaggerated in the subgroup with silent exertional ischaemia. 
